Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 19Recruiting 7Unknown 6Active not recruiting 5Withdrawn 3Terminated 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 20Gastrointestinal 18Head & Neck 14CNS 14Genitourinary 12Breast 10Sarcoma 9Other hematologic neoplasm 8Lymphoid 8Dermatologic 6Tumor-Agnostic 3Other solid neoplasm 3Myeloid 3Gynecologic 3Other 2Endocrine 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 3Vaginal Neoplasms 1Carcinoma, Endometrioid 1

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Radiation × Gynecologic × Clear all
NCT03527264 2025-04-04

BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer

Brown University

Phase 2 Terminated
4 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms

NCT03345784 2024-02-20

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

National Cancer Institute (NCI)

Phase 1 Terminated
10 enrolled 15 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms, Carcinoma, Endometrioid

NCT01194609 2014-05-09

A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer

Korea Cancer Center Hospital

Phase 1/2 Terminated
2 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡